David Chase SR. in Booneville, Mississippi

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: University Of Mississippi School Of Medicine
Graduation Year: 1977
The Primary Medical Specialty for David Chase SR. is listed as: Pulmonary Disease
Approximate Years of Experience: 47
PAC (PECOS ID)#: 4981777117
NPI #: 1588623532
NPI Created On: 03/20/2006
NPI Last Updated Listed as: 10/19/2012
Primary Taxonomy Code: 174400000X
License Number:
07824
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Ambetter
• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Examination of lung airways using an endoscope
2. Aspiration of lung secretions from lung airways using an endoscope
3. Vaccine for influenza for administration into muscle, 0.5 ml dosage
4. Vaccine for influenza for administration into muscle, 0.5 ml dosage
5. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
7. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
9. Follow-up or limited ultrasound examination of heart
10. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
11. Measurement and graphic recording of total and timed exhaled air capacity
12. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
13. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
14. Diagnostic testing in a pulmonary function lab
15. Diagnostic testing in a pulmonary function lab
16. Test for exercise-induced heart and lung stress
17. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
18. Determination of lung volumes using plethysmography
19. Determination of lung volumes using gas dilution or washout
20. Measurement of lung diffusing capacity